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Abstract
Introduction: Though uncommon, extramedullary plasmacytoma of the pancreas should be
considered in the differential diagnosis of obstructive jaundice and pancreatic neoplasms. This report
highlights a case of obstructive jaundice in a 46-year-old West Indian man that resulted from an
extramedullary plasmacytoma.
Case presentation: A 46-year-old West Indian man presented to our hospital with evidence of a
significant upper gastrointestinal bleed. He gave a recent history of jaundice, constitutional symptoms
and back pain. Ultrasonography revealed a mass in the head of the pancreas with resultant common
bile duct dilatation. The patient required urgent surgical intervention for ongoing bleeding at which
time a biopsy of the pancreas was taken. Histological analysis revealed a plasmacytoma of the
pancreas. A blood film showing rouleaux formation and a skeletal survey demonstrating multiple lytic
lesions confirmed multiple myeloma. Before further evaluation or treatment was carried out, the
patient defaulted from follow-up and died from his illness seven months later.
Conclusion: This case represents an example of multiple myeloma with visceral involvement,
brought to clinical attention through involvement of the pancreas. The report serves to reaffirm
knowledge of the various presentations, the optimal diagnostic tools and the current proposed
treatment strategies for extramedullary plasmacytomas of the pancreas.
Introduction
Extramedullary plasmacytoma represents an uncommon
variant of plasma cell tumors involving organs outside the
bone marrow. They are typically identified after the
diagnosis of multiple myeloma. The following case report
describes such a tumor involving the pancreas, presenting
with obstructive jaundice and mimicking an adeno-
carcinoma of the pancreas.
Case presentation
A 46-year-old West Indian man presented to our
emergency department with a two-day history of
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associated with coffee-ground vomitus and symptoms of
anemia. He gave a past history of peptic ulcer disease. He
had no history of non-steroidal anti-inflammatory drug
(NSAID) use. Three weeks previously, the patient had
noted jaundice associated with pruritus, dark urine,
constitutional symptoms and back pain. Examination
revealed the patient to be anemic, jaundiced and
hemodynamically normal. Minimal epigastric tenderness
was elicited and a Courvoisier’s gall bladder palpated.
Digital rectal examination revealed altered blood, and
nasogastric drainage revealed coffee-ground material.
A diagnosis of an upper gastrointestinal bleed secondary
to peptic ulcer disease was made. However, diagnoses of
periampullary pancreatic carcinoma or locally advanced
gastric carcinoma were also considered. Initial blood
investigations revealed a hemoglobin level of 8.9 g/dL.
Coagulation studies and electrolytes were normal. Liver
function tests suggested obstructive jaundice. Abdominal
sonography showed a normal liver with a distended
(109 mL) gall bladder and dilated biliary system. The
pancreas appeared bulky and heterogeneous.
Further evaluation of the pancreatic lesion was planned.
However, our patient’s condition became complicated by
persistent bleeding from the rectum and a resultant fall
in his hemoglobin level to 4.4 g/dL over a 2-day period.
Though he remained hemodynamically normal, limited
blood availability, continued bleeding and the unavail-
ability of endoscopy prompted a decision to proceed to
laparotomy. At laparotomy, an actively bleeding ulcer was
identified in the first part of the duodenum and it was
oversewn with good effect. A bosselated mass, not related
to the ulcer, was noted occupying the head and neck of
the pancreas. There was no evidence of local invasion.
A biopsy of the pancreatic mass was taken.
The patient’s postoperative course was uneventful and he
was discharged five days postoperatively. Histological
analysis of the pancreatic biopsy revealed plasmacytoma
(Figures 1 and 2). Following this diagnosis, appropriate
investigations for multiple myeloma were initiated in
the outpatient clinic. Rouleaux formation was noted on
blood film, and lytic lesions were noted in the skull, pelvis
and proximal femora (Figure 3), both humeri, scapulae,
clavicles and in multiple ribs. A complete collapse of
the 7th thoracic vertebra was also evident. Based on
these findings, the patient was re-evaluated as having
multiple myeloma with extramedullary plasmacytoma of
the pancreas. Unfortunately, the patient defaulted from
follow-up before further investigation and treatment,
including bone marrow biopsy, and died from his illness
seven months after initial presentation.
Discussion
Multiple myeloma is a malignant hematologic neoplasm
characterized by the uncontrolled proliferation of clonal
plasma cells and accounts for 10% of malignant hemato-
logic neoplasms and 1% of neoplasms overall [1].
Typically, multiple myeloma is a disease of middle-aged
and older people with peak incidence in the 6th and 7th
decades of life. Its predominant bone marrow involve-
ment results in anemia, hypercalcemia with renal impair-
ment and impaired immunity. This skeletal involvement
Figure 1. Low-power view of pancreatic biopsy showing
residual pancreatic acini centrally, surrounded by a dense
infiltrate of smaller cells (hematoxylin and eosin stain, ×100).
Figure 2. High-power view of the pancreatic biopsy
exhibiting characteristic nuclear features of plasma cells
(hematoxylin and eosin stain, ×400).
Page 2 of 4
(page number not for citation purposes)
Journal of Medical Case Reports 2009, 3:8785 http://jmedicalcasereports.com/jmedicalcasereports/article/view/8785results, classically, in ‘punched out’ lytic lesions on
radiography [2].
A plasmacytoma represents a discrete, often solitary, mass
of neoplastic plasma cells which may occupy medullary
or soft tissue, that is, extramedullary, sites [3]. Extrame-
dullary plasmacytomas account for 5% of all plasma
cell neoplasms [4]. They are more commonly related to
underlying multiple myeloma. Rarely, there may be no
evidence of bone marrow involvement (<5% plasma cells
and normal bone scan), with the plasmacytomas occur-
ring either de novo or secondary to another extramedullary
plasmacytoma.
The most frequent sites of extramedullary plasmacytomas
are the nasalfossae and other parts of the upper respiratory
tract. Other typical extraosseous sites of plasmacytoma
include the liver, spleen and lymph nodes. When the
pancreas is involved, it may be the sole site [5,6] or there
may be coexistent involvement of other organs such as the
stomach and bladder [2]. To date, just over 20 clinical
cases of extramedullary plasmacytomas involving the
pancreas have been reported in the English language
literature. Most have been identified in patients already
known to have underlying multiple myeloma or other
extramedullary plasmacytomas. In our patient, the diag-
nosis of multiple myeloma was made immediately
following the diagnosis of the plasmacytoma of the
pancreas.
The typical presentation of extramedullary plasmacytomas
of the pancreas includes jaundice and abdominal pain,
often related to obstruction of the biliary tree. The
radiologic features are non-specific. Ultrasonography
typically demonstrates a heterogeneous focal mass which
is hypoechoic relative to the normal parenchyma. It is
most often located in the head of the pancreas [7].
Computed tomography (CT) findings of a focal multi-
lobulated mass with homogeneous intravenous contrast
enhancement have been described more commonly,
though diffuse pancreatic enlargement may be appreciated
[6]. Dual phase acquisition CT with pancreatic protocol is
considered the investigation of choice as it demonstrates
improved detection of hypovascular and hypervascular
lesions [2]. Magnetic resonance imaging (MRI) has limited
documented use for the detection of extramedullary
plasmacytomas of the pancreas, though some authors
suggest that this modality may be better in demonstrating
pancreatic infiltration than CT [6]. It is felt that the
development of fast CT scans with multiphasic capabil-
ities, particularly in the arterial phase, will improve the
detection of extraosseous manifestations of multiple
myeloma [2].
The use of endoscopic retrograde cholangiopancreato-
graphy (ERCP) in the diagnosis has not been reported
widely. Abu-Hammour et al. [8] noted biliary obstruction
related to a mass in the head of the pancreas. ERCP
demonstrated smooth strictures, dilated common bile
duct and proximal pancreatic duct. Hirata et al. [4]
suggested that the demonstration of a smooth stenosis
of the biliary tree was more suggestive of a plasmacytoma
than adenocarcinoma where irregular stenosis is classical.
The definitive diagnosis is usually confirmed by open
biopsy as the risk of dissemination of malignant cells with
percutaneous biopsy has made this route unpopular [4].
Conventional treatment for multiple myeloma involves
steroid-chemotherapy combinations and radiotherapy for
symptomatic lesions. Newer modalities being investigated
include thalidomide, antiangiogenic agents and stem
cell transplantation [9]. There appears to be no standar-
dized treatment for extramedullary plasmacytomas of
the pancreas however. External beam radiotherapy,
chemotherapy and bypass procedures, alone or in
combination, have been described. Owing to the highly
radiosensitive nature of plasma cell tumors, radiation
therapy has been suggested to be the treatment of choice
[4]. Surgical procedures, other than distal pancreatectomy
for isolated pancreatic tail involvement, are not commonly
performed owing to the often systemic nature of the
disease and the radical nature of these surgical procedures
[4]. Unsuspected cases may undergo pancreatic resection
typical for pancreatic lesions with subsequent identifica-
tion of plasma cells [10]. Chemotherapeutic agents are
commonly used, particularly when plasmacytomas are
secondary in nature. Of the cases mentioned in the
literature, only one patient had therapeutic surgical
resection, four had chemotherapy alone, five had
Figure 3. Plain radiograph of the pelvis and proximal femora
showing extensive lytic lesions.
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therapy and chemotherapy [4,11]. Of those patients who
underwent radiotherapy or chemotherapy, resolution of
biliary obstruction was noted in the majority thus
avoiding the need for surgical bypass or stenting [4,11].
Survival in these patients is related to the underlying
systemic illness. Consequently, the course for extramedul-
lary plasmacytoma not related to multiple myeloma is
more favorable than that of multiple myeloma or solitary
plasmacytoma of the bone. Life expectancy related to
extramedullary plasmacytoma of the pancreas has been
quoted as 1 day to 6 years in the literature [4].
In our patient, even if resolution of obstructive jaundice
was achieved with the institution of radiotherapy and
chemotherapy, his overall prognosis would have been
guarded based on the systemic component of the disease.
Conclusion
This report represents a rare case of extramedullary
plasmacytoma of the pancreas. It re-emphasizes the need
to consider all possible differentials when evaluating
pancreatic masses. Owing to its uncommon nature, the
comparative assessment of treatment modalities is not
feasible. In the absence of such evidence, extrapolation
from the treatment of multiple myeloma seems reason-
able and has been shown to improve the extent of
obstructive jaundice in these patients.
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